Posted on 6/1/18
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine . . .
Posted on 6/1/18
T2 Biosystems Announces Pricing of Public Offering of Common Stock
LEXINGTON, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the pricing of an underwritten registered public offering of 6,100,000 shares of . . .
Posted on 5/31/18
FORMA Therapeutics and HitGen Initiate Multiyear Research Collaboration
WATERTOWN, Mass. & CHENGDU, China--(BUSINESS WIRE)--FORMA Therapeutics and HitGen Ltd. today announced a multiyear research collaboration and license agreement to build and screen proprietary DNA-encoded libraries . . .
Posted on 5/31/18
Medley Genomics Awarded NCI SBIR to Advance Development of Novel Data Analytics for Personalized Cancer Treatments
Medley Genomics announced today that it has been awarded a Phase I SBIR grant for $299,670 from the National Cancer Institute (NCI) entitled "Combining Next-Generation Sequencing . . .
Posted on 5/31/18
Sesen Bio Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio, Inc. (Nasdaq: SESN), a late-stage clinical company developing next-generation antibody-drug conjugate therapies for the treatment of cancer, today announced that it intends . . .
Posted on 5/30/18
Vericel Corp. Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, . . .
Posted on 5/30/18
U.S. Department of Defense Awards $2M Grant to Frequency Therapeutics
WOBURN, Mass. & FARMINGTON, Conn.--(BUSINESS WIRE)--Frequency Therapeutics today announced the receipt of a U.S. Department of Defense Hearing and Balance Research Award grant. The $2 million . . .
Posted on 5/30/18
AbCellera and Harbour Antibodies Announce Technology Co-Offering Agreement
VANCOUVER, British Columbia & ROTTERDAM, Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--AbCellera and Harbour Antibodies, a Harbour BioMed subsidiary, announced today that they have entered into an agreement . . .
Posted on 5/29/18
Curis Announces Effectiveness of 1-for-5 Reverse Stock Split
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that . . .
Posted on 5/29/18
T2 Biosystems Announces Proposed Public Offering of Common Stock
LEXINGTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq:TTOO), an emerging leader in the development and commercialization of innovative diagnostic products for critical . . .
Posted on 5/29/18
Melinta Therapeutics Announces Closing of Underwritten Public Offering
NEW HAVEN, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial . . .
Posted on 5/28/18
Bicycle Therapeutics Announces Clinical Milestone & Expands Collaboration with ThromboGenics
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, today announced . . .
Posted on 5/25/18
Better Buy: Bellicum Pharmaceuticals, Inc. vs. bluebird bio
Bellicum Pharmaceuticals (NASDAQ:BLCM) and bluebird bio (NASDAQ:BLUE) are both clinical-stage biotechs that are developing cutting-edge therapies to treat cancer and other diseases. But the fortunes of . . .
Posted on 5/25/18
Sectra Wins PACS Order at Pediatric Orthopedic Hospital
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will install its enterprise imaging PACS at Texas Scottish Rite Hospital for Children. The Sectra . . .
Posted on 5/25/18
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today . . .
Posted on 5/25/18
Bicycle Therapeutics Expands Strategic Partnership with AstraZeneca
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics, a biotechnology company pioneering a new class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) product platform, announced today . . .
Posted on 5/25/18
Biopharma Company Kiniksa Goes Public
NEW YORK, May 24, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq:KNSA), a clinical-stage biopharmaceutical company, visited the Nasdaq MarketSite in Times Square today for its . . .
Posted on 5/24/18
Karyopharm and Antengene Sign Exclusive License Agreement
NEWTON, Mass. and SHANGHAI, China, May 24, 2018 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) (Karyopharm) and Antengene Corporation (Antengene), today announced their entry into an . . .
Posted on 5/24/18
Berkshire Hathaway vs. Vanguard S&P 500 ETF: Which Should You Choose?
As one of the most respected stock-pickers of all time, Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) CEO Warren Buffett's favorite investment for most Americans may come as a surprise. . . .
Posted on 5/24/18
Scholar Rock Announces Pricing of IPO
CAMBRIDGE, Mass., May 23, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ:SRRK), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment . . .
Posted on 5/24/18
Anika Therapeutics Announces $30 Million Accelerated Share Repurchase
BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, . . .
Posted on 5/24/18
Melinta Therapeutics Prices Public Offering of Common Stock
NEW HAVEN, Conn., May 23, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial . . .
Posted on 5/23/18
Healthcare Referral Management Company par8o Announces Completion of Nationwide Platform Upgrade
par8o, the largest referral management provider in the US, announced the completion of a system-wide platform upgrade. The technology enhancement was completed in mid-May following a . . .
Posted on 5/23/18
Circulation Teams Up with AI Powered Buoy Health
BOSTON--(BUSINESS WIRE)--Circulation Health (www.circulation.com), a ride-ordering exchange that coordinates medical transportation logistics using Lyft and other transportation partners, today announced that it has entered into a . . .
Posted on 5/23/18
Curis Announces 1-for-5 Reverse Stock Split
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of cancer, today announced that . . .

